SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Mark Bong who wrote (3965)6/2/2001 6:23:03 PM
From: Biotech Jim  Read Replies (2) | Respond to of 52153
 
In my opinion the federal charges against Takeda Abbott Partners (TAP) will either be substantially reduced or will not hold. Check into them carefully regarding the charges made public. The bigger issues are the antagonist vs agonist story, and the female possible uses for endometriosis inter alia. They favor PRCS by a long shot.

BJ